Invesco
DNA icon

Invesco’s Ginkgo Bioworks DNA Stock Holding History

Invesco’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
211,723
-23,085
-10% -$193K ﹤0.01% 2560
2026
Q1 		$1.44M Sell
234,808
-26,898
-10% -$224K ﹤0.01% 2703
2025
Q4 		$2.17M Buy
261,706
+50,565
+24% +$544K ﹤0.01% 2581
2025
Q3 		$3.08M Buy
211,141
+51,336
+32% +$614K ﹤0.01% 2447
2025
Q2 		$1.8M Buy
159,805
+66,121
+71% +$512K ﹤0.01% 2608
2025
Q1 		$534K Buy
93,684
+67,130
+253% +$684K ﹤0.01% 3122
2024
Q4 		$261K Sell
26,554
-160
-0.6% -$1.37K ﹤0.01% 3456
2024
Q3 		$218K Sell
26,714
-430
-2% -$4.31K ﹤0.01% 3496
2024
Q2 		$363K Sell
27,144
-28,367
-51% -$846K ﹤0.01% 3421
2024
Q1 		$2.58M Buy
55,511
+17,545
+46% +$908K ﹤0.01% 2549
2023
Q4 		$2.57M Buy
37,966
+2,321
+7% +$142K ﹤0.01% 2524
2023
Q3 		$2.58M Buy
35,645
+314
+0.9% +$25.1K ﹤0.01% 2505
2023
Q2 		$2.63M Buy
35,331
+3,702
+12% +$219K ﹤0.01% 2548
2023
Q1 		$1.68M Buy
31,629
+14,879
+89% +$943K ﹤0.01% 2704
2022
Q4 		$1.13M Buy
16,750
+3,018
+22% +$278K ﹤0.01% 2878
2022
Q3 		$1.71M Sell
13,732
-1,184
-8% -$141K ﹤0.01% 2706
2022
Q2 		$1.42M Buy
+14,916
New +$1.82M ﹤0.01% 2851

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Invesco's DNA Position: Q2 2026 in Review

Invesco reduced its Ginkgo Bioworks (DNA) stake by 9.8% in Q2 2026, selling an estimated $193K and leaving 211,723 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2560.

Invesco first reported a position in DNA in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.08M in Q3 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Invesco held 211,723 shares of Ginkgo Bioworks worth $2.1M as of Q2 2026.
  • Invesco sold 23,085 Ginkgo Bioworks shares in Q2 2026, an estimated $193K.
  • Ginkgo Bioworks made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2560 holding.
  • Invesco first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 17 quarters since.
  • Invesco's Ginkgo Bioworks position peaked at $3.08M in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.